CSF2 and neoplasm: DC vaccine preparation involves the isolation of CD-14 positive monocytes from the patient, loading of tumor antigens into the immature DCs, treatment of the DCs with the cytokines (GM-CSF and IL-4) to induce maturity, and finally the preparation of human DC vaccines for re-injection into GB patients [763,764,765].